| Analysis | Metabolite Name | Measured Value | Units | Group | Timepoint | Gender | Age at start of study |
|---|---|---|---|---|---|---|---|
| GC POSITIVE ION MODE | 4-hydroxybenzoate | 285 | Counts | NA | NA | NA | - |
| GC POSITIVE ION MODE | 4-hydroxybenzoate | 420 | Counts | Synbiotic | Recovery (days 631-633) | Male castrated | 3 |
| GC POSITIVE ION MODE | 4-hydroxybenzoate | 619 | Counts | Synbiotic | Completion of treatment (days 26-28) | Male castrated | 5 |
| GC POSITIVE ION MODE | 4-hydroxybenzoate | 665 | Counts | Placebo | Completion of treatment (days 26-28) | Female spayed | 6 |
| GC POSITIVE ION MODE | 4-hydroxybenzoate | 689 | Counts | Synbiotic | Completion of treatment (days 26-28) | Male castrated | 5 |
| GC POSITIVE ION MODE | 4-hydroxybenzoate | 798 | Counts | Placebo | Completion of treatment (days 26-28) | Male castrated | 6 |
| GC POSITIVE ION MODE | 4-hydroxybenzoate | 868 | Counts | Placebo | Completion of treatment (days 26-28) | Female spayed | 7 |
| GC POSITIVE ION MODE | 4-hydroxybenzoate | 949 | Counts | Synbiotic | Completion of treatment (days 26-28) | Male castrated | 3 |
| GC POSITIVE ION MODE | 4-hydroxybenzoate | 1007 | Counts | Placebo | Completion of treatment (days 26-28) | Male castrated | 6 |
| GC POSITIVE ION MODE | 4-hydroxybenzoate | 1062 | Counts | Placebo | Completion of treatment (days 26-28) | Male castrated | 5 |
| GC POSITIVE ION MODE | 4-hydroxybenzoate | 1135 | Counts | Placebo | Completion of treatment (days 26-28) | Male castrated | 5 |
| GC POSITIVE ION MODE | 4-hydroxybenzoate | 1148 | Counts | Synbiotic | Completion of treatment (days 26-28) | Female spayed | 6 |
| GC POSITIVE ION MODE | 4-hydroxybenzoate | 1182 | Counts | Placebo | Completion of treatment (days 26-28) | Female spayed | 8 |
| GC POSITIVE ION MODE | 4-hydroxybenzoate | 1254 | Counts | Synbiotic | Completion of treatment (days 26-28) | Male castrated | 6 |
| GC POSITIVE ION MODE | 4-hydroxybenzoate | 1411 | Counts | Placebo | Completion of treatment (days 26-28) | Female spayed | 3 |
| GC POSITIVE ION MODE | 4-hydroxybenzoate | 1629 | Counts | Synbiotic | Completion of treatment (days 26-28) | Female spayed | 8 |
| GC POSITIVE ION MODE | 4-hydroxybenzoate | 1938 | Counts | Synbiotic | Completion of treatment (days 26-28) | Male castrated | 5 |
| GC POSITIVE ION MODE | 4-hydroxybenzoate | 1940 | Counts | Synbiotic | Completion of treatment (days 26-28) | Female spayed | 3 |
| GC POSITIVE ION MODE | 4-hydroxybenzoate | 3972 | Counts | Placebo | Baseline (days 5-7) | Male castrated | 5 |
| GC POSITIVE ION MODE | 4-hydroxybenzoate | 4231 | Counts | Synbiotic | Baseline (days 5-7) | Male castrated | 5 |
| GC POSITIVE ION MODE | 4-hydroxybenzoate | 5015 | Counts | Placebo | Baseline (days 5-7) | Female spayed | 6 |
| GC POSITIVE ION MODE | 4-hydroxybenzoate | 5604 | Counts | Placebo | Baseline (days 5-7) | Female spayed | 8 |
| GC POSITIVE ION MODE | 4-hydroxybenzoate | 6100 | Counts | Placebo | Baseline (days 5-7) | Male castrated | 6 |
| GC POSITIVE ION MODE | 4-hydroxybenzoate | 6975 | Counts | Placebo | Baseline (days 5-7) | Male castrated | 5 |
| GC POSITIVE ION MODE | 4-hydroxybenzoate | 7764 | Counts | Synbiotic | Recovery (days 631-633) | Female spayed | 8 |
| GC POSITIVE ION MODE | 4-hydroxybenzoate | 8232 | Counts | Placebo | Recovery (days 631-633) | Female spayed | 8 |
| GC POSITIVE ION MODE | 4-hydroxybenzoate | 9225 | Counts | Synbiotic | Baseline (days 5-7) | Male castrated | 5 |
| GC POSITIVE ION MODE | 4-hydroxybenzoate | 9240 | Counts | Placebo | Baseline (days 5-7) | Male castrated | 6 |
| GC POSITIVE ION MODE | 4-hydroxybenzoate | 10605 | Counts | Synbiotic | Baseline (days 5-7) | Male castrated | 5 |
| GC POSITIVE ION MODE | 4-hydroxybenzoate | 11024 | Counts | Synbiotic | Baseline (days 5-7) | Female spayed | 6 |
| GC POSITIVE ION MODE | 4-hydroxybenzoate | 11175 | Counts | NA | NA | NA | - |
| GC POSITIVE ION MODE | 4-hydroxybenzoate | 12022 | Counts | Synbiotic | Baseline (days 5-7) | Female spayed | 3 |
| GC POSITIVE ION MODE | 4-hydroxybenzoate | 12478 | Counts | Synbiotic | Baseline (days 5-7) | Female spayed | 8 |
| GC POSITIVE ION MODE | 4-hydroxybenzoate | 12659 | Counts | NA | NA | NA | - |
| GC POSITIVE ION MODE | 4-hydroxybenzoate | 12840 | Counts | NA | NA | NA | - |
| GC POSITIVE ION MODE | 4-hydroxybenzoate | 13048 | Counts | Synbiotic | Recovery (days 631-633) | Male castrated | 6 |
| GC POSITIVE ION MODE | 4-hydroxybenzoate | 13339 | Counts | NA | NA | NA | - |
| GC POSITIVE ION MODE | 4-hydroxybenzoate | 13355 | Counts | NA | NA | NA | - |
| GC POSITIVE ION MODE | 4-hydroxybenzoate | 13765 | Counts | NA | NA | NA | - |
| GC POSITIVE ION MODE | 4-hydroxybenzoate | 13830 | Counts | Synbiotic | Baseline (days 5-7) | Male castrated | 3 |
| GC POSITIVE ION MODE | 4-hydroxybenzoate | 13833 | Counts | NA | NA | NA | - |
| GC POSITIVE ION MODE | 4-hydroxybenzoate | 14302 | Counts | Placebo | Recovery (days 631-633) | Female spayed | 6 |
| GC POSITIVE ION MODE | 4-hydroxybenzoate | 14378 | Counts | Placebo | Recovery (days 631-633) | Male castrated | 5 |
| GC POSITIVE ION MODE | 4-hydroxybenzoate | 14574 | Counts | NA | NA | NA | - |
| GC POSITIVE ION MODE | 4-hydroxybenzoate | 14587 | Counts | NA | NA | NA | - |
| GC POSITIVE ION MODE | 4-hydroxybenzoate | 15135 | Counts | Placebo | Baseline (days 5-7) | Female spayed | 7 |
| GC POSITIVE ION MODE | 4-hydroxybenzoate | 15156 | Counts | NA | NA | NA | - |
| GC POSITIVE ION MODE | 4-hydroxybenzoate | 16292 | Counts | Placebo | Recovery (days 631-633) | Male castrated | 5 |
| GC POSITIVE ION MODE | 4-hydroxybenzoate | 16643 | Counts | Synbiotic | Recovery (days 631-633) | Male castrated | 5 |
| GC POSITIVE ION MODE | 4-hydroxybenzoate | 17030 | Counts | Synbiotic | Baseline (days 5-7) | Male castrated | 6 |
| GC POSITIVE ION MODE | 4-hydroxybenzoate | 17134 | Counts | Synbiotic | Recovery (days 631-633) | Male castrated | 5 |
| GC POSITIVE ION MODE | 4-hydroxybenzoate | 17254 | Counts | Placebo | Recovery (days 631-633) | Female spayed | 7 |
| GC POSITIVE ION MODE | 4-hydroxybenzoate | 20316 | Counts | Placebo | Recovery (days 631-633) | Female spayed | 3 |
| GC POSITIVE ION MODE | 4-hydroxybenzoate | 21942 | Counts | Placebo | Recovery (days 631-633) | Male castrated | 6 |
| GC POSITIVE ION MODE | 4-hydroxybenzoate | 23719 | Counts | Placebo | Recovery (days 631-633) | Male castrated | 6 |
| GC POSITIVE ION MODE | 4-hydroxybenzoate | 27743 | Counts | Placebo | Baseline (days 5-7) | Female spayed | 3 |
| GC POSITIVE ION MODE | 4-hydroxybenzoate | 29967 | Counts | Synbiotic | Recovery (days 631-633) | Female spayed | 3 |
| GC POSITIVE ION MODE | 4-hydroxybenzoate | 49060 | Counts | Synbiotic | Recovery (days 631-633) | Female spayed | 6 |
- UCSD Metabolomics Workbench, a resource sponsored by the Common Fund of the National Institutes of Health
|